Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TopChem Pharmaceuticals is an Irish-based developer and manufacturer of niche Active Pharmaceutical Ingredients (APIs) and low-volume, high-value chemical products. Founded in 2007 and headquartered in Sligo, the company specializes in the development of complex chemical processes and the production of controlled substances under strict GMP standards. Their core business involves providing contract development and manufacturing services to the global pharmaceutical industry, with a particular focus on specialty and niche generic markets. In 2022, TopChem was acquired by Adalvo, a leading global B2B pharmaceutical company, which has integrated TopChem's manufacturing capabilities into its broader specialty medicine portfolio. The company's facility is regularly inspected by the FDA and the Health Products Regulatory Authority (HPRA), ensuring high-quality standards for its international client base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TopChem Pharmaceuticals.